Pasi A. Jänne, MD, PhD is a translational thoracic oncologist, Director of the Lowe Center for Thoracic Oncology and a Professor of Medicine at Harvard Medical School. After earning his MD and PhD from the School of Medicine at the University of Pennsylvania, Dr. Jänne completed his internship and residency in Medicine at Brigham and Women’s Hospital, Boston and oncology fellowship training at Dana-Farber Cancer Institute in 2001. He has made seminal therapeutic discoveries, including being on one of the co-discoverers of EGFR mutations, and findings from his work has led to the development of several clinical trials and new therapies for lung cancer patients.